The more
aggressive control of blood pressure among patients at high risk for coronary
artery disease such as those with coronary artery disease, a 10-year Framingham
risk score ≥10%, diabetes mellitus, chronic kidney disease, or other coronary
artery risk equivalent with maintenance of the blood pressure below 130/80 mm
Hg and below 120/80 mm Hg in patients with left ventricular dysfunction
recommended by the American Heart Association (AHA) Task Force scientific statement
in 2007 was based upon expert medical opinion at that time, not on prospective,
randomized, adequately controlled trial data.
The Pravastatin
or Atorvastatin Evaluation and Infection Therapy- Thrombolysis in Myocardial
Infarction (PROVE IT-TIMI) 22 trial enrolled 4,162 patients with an acutecoronary syndrome (acute myocardial infarction with or without ST-segment
elevation or highrisk unstable angina pectoris).The lowest incidence of
cardiovascular events occurred with a systolic blood pressure between 130 to
140 mm Hg and a diastolic blood pressure between 80 to 90 mm Hg with a nadir of
136/85 mm. Read more....................
No comments:
Post a Comment